Biphasic Calcium Phosphate Composite for Biomedical Applications

Sukhodub, L.B.; Kulak, A.I.; Inshyna, Nataliia Mykolaivna; Kuznetsov, V.N.; Stanislavov, A.S.; Sukhodub, Leonid Fedorovych

Please use this identifier to cite or link to this item: http://essuir.sumdu.edu.ua/handle/123456789/35448

Or use following links to share this resource in social networks: Recommend this item

Title	Biphasic Calcium Phosphate Composite for Biomedical Applications
Authors	Sukhodub, L.B. Kulak, A.I. Inshyna, Nataliia Mykolaivna Kuznetsov, V.N. Stanislavov, A.S. Sukhodub, Leonid Fedorovych
ORCID	http://orcid.org/0000-0002-8204-8547 http://orcid.org/0000-0002-1559-0475
Keywords	Hydroxyapatite Tricalcium Phosphate Biphasic Composite Heat Treatment XRD SEM
Type	Conference Papers
Date of Issue	2013
URI	http://essuir.sumdu.edu.ua/handle/123456789/35448
Publisher	Sumy State University
License	Copyright not evaluated
Citation	Biphasic Calcium Phosphate Composite for Biomedical Applications [Текст] / V.N. Kuznetsov, L.B. Sukhodub, A.S. Stanislavov et al. // Nanomaterials: Applications & Properties (NAP-2013) : 2-nd International conference, Alushta, the Crimea, September 17-22, 2012 / Edited by: A. Pogrebnjak. - Sumy : Sumy State University, 2013. - V.2, No4. - 04NABM15
Abstract	The paper describes the preparation of the biphasic (hydroxyapatite (HA) and tricalcium phosphate (TCP)) nanostructured calcium phosphate composite. The product was chemically synthesized from the solution which contained calcium acetate Са(СН3СОО)2 (0,167 mМ), sodium dihydrogen phosphate NaH2PO4 (0,1 mМ), sodium hydrocarbonate NaHCO3 (0,02 mM). The calcium phosphate composite was formed at pH=11 with and without the addition of carbonate ions. The samples were analyzed using X-Ray diffraction after the heat treatment at 900C for 1 h. The derived material contained HA and TCP phases with their contents change depending on the concentration of the carbonate ions in the solution. The mean crystallite size of the HA phase in (121) plane is 12 – 14 nm. Further studies will be directed to the using of the derived composite for the biomedical applications. When you are citing the document, use the following link http://essuir.sumdu.edu.ua/handle/123456789/35448
Appears in Collections:	Наукові видання (ЕлІТ)